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Introduction: The aims of the present study were: (a) to examine the agreement between subjective (assessed via
the International Physical Activity Questionnaire; IPAQ) and objective (accelerometry; GT3X) physical activity (PA)
levels in patients with rheumatoid arthritis (RA), and (b) to evaluate the associations of RA patients’ subjective and
objective PA to their scores on the maximal oxygen uptake test (VO2max).
Methods: The participants wore the GT3X for seven days before completing the IPAQ and VO2max test. The
Bland-Altman plot was used to illustrate the agreement between the objective and subjective PA data, and the
Wilcoxon test was employed to examine the differences. The association between the PA measurement and
VO2max test was examined via the correlations and the magnitude was presented by the Steiger’s Z value.
Results: Sixty-eight RA patients (age = 55 ± 13 years, body mass index: 27.8 ± 5.4 kg/m2, median of disease
duration = 5 (2–8) yrs) were recruited. Smaller differences between the subjective and objective measures were
found when PA was assessed at the moderate level. Wilcoxon tests revealed that patients reported less time spent
engaged in sedentary behaviours (Z = −6.80, P < 0.01) and light PA (Z = −6.89, P < 0.01) and more moderate PA
(Z = −6.26, P < 0.01) than was objectively indicated. Significant positive correlations were revealed between VO2max
with all PA levels derived from accelerometry (light PA rho = .35, P < .01; moderate PA rho = .34, P = .01; moderate
and vigorous PA, (MVPA) rho = .33, P = .01), and a negative association to sedentary time (ST) emerged (rho = −.27,
P = .04). IPAQ-reported moderate PA and MVPA positively correlated with maxV02 (rho = .25, P = .01, rho = .27,
P = .01, respectively). Differences between the magnitude of correlations between the IPAQ-VO2 max and GT3X-VO2
max were only significant for ST (Z = 3.43, P < .01).
Conclusions: Via responses to the IPAQ, RA patients reported that they were less sedentary and engaged in more
higher intensity PA than what was objectively assessed. Accelerometry data correlated with VO2max at all PA levels.
Only subjective moderate and MPVA correlated with VO2max. Findings suggest that self-reported PA and ST should
be interpreted with caution in people with RA and complemented with accelerometry when possible.
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Table 1 Demographic characteristics and medication of
RA patients
Demographic characteristics Mean±SD/Mean (%)
Age, mean ± SD years 55 ± 13
Women (%) 42 (62%)
Height, mean ± SD 168.2 ± 9.3
BMI, mean ± SD years 27.8 ± 5.4
Disease duration, mean ± SD years 7.2 ± 8.7
Medication Number (%)
Methotrexate 50 (74)
Other DMARDs 35 (52)
Anti-TNF Therapy 8 (12)
Other Biologics 2 (3)
Prednisolone 11 (16)
NSAIDs 24 (35)
Analgesics 25 (37)
Cholesterol-reducing 18 (27)
Anti-Hypertensives 16 (24)
BMI, body mass index; DMARDs, disease-modifying anti-rheumatic drugs;
NSAIDs, non-steroidal anti-inflammatory drugs; RA, rheumatoid arthritis.
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Rheumatoid arthritis (RA), the most common inflamma-
tory musculoskeletal disease, is characterized by joint
swelling, pain and bone destruction but also a greater
risk of cardiovascular disease (CVD) [1,2]. The latter has
been partly attributed to an increased prevalence of clas-
sical CVD risk factors [3-5] and the effects of high-grade
inflammation on the vasculature [6,7]. Another import-
ant factor that may lead to an increased CVD risk in RA
is low levels of physical activity (PA) [8,9]. RA patients
can and should engage in PA, as exercise may slow down
disease progression and improve physical ability [10].
Nevertheless, it is repeatedly shown that PA levels are sig-
nificantly lower in RA compared to the general population
[11-14]. It seems, therefore, important that accurate
methods should be available to both evaluate and monitor
PA levels in RA patients.
There are two ways of measuring PA, namely subject-
ive and the objective methods, which are distinguished
on how the data are collected. To date, subjective PA is
predominantly measured via self-reported means, given
that this method is easy to administer, low cost, and
more efficient at gathering data from larger samples [15].
However, self-reported PA is subject to different types of
bias [16] due to lack of understanding and/or differential
perceptions of item content when employed in different
populations. Due to increased physical disability there
may be a risk of RA patients to over-report their PA. Fur-
ther, it is not clear how self- reported PA corresponds to
indicators of physical function in RA patients. On the
other hand, accelerometry is one of the most frequent
ways of measuring objective PA, as the device is light to
carry and non-invasive [17]. Although the accelerometer
is not the most accurate assessment of objective PA as-
sessment, data obtained from accelerometry are generated
in real time and have been validated [18] in both field and
lab settings [19]. Increased PA is a behaviour that results
in physiological adaptations that, in turn, may prevent or
improve disease-related factors and CVD risk in RA pa-
tients [11,20]. This beneficial association is strongly sup-
ported by a robust inverse relationship of CVD morbidity
and mortality with cardiorespiratory fitness, assessed via
the ‘gold standard’ method, namely, the maximal oxygen
uptake (VO2max) test [21,22]. Therefore, the aims of the
present study were to: 1) examine the agreement between
subjective (questionnaire) and objective (accelerometry)
levels of PA in RA patients, and 2) investigate the associa-
tions of these two assessments against VO2max.
Methods
Participants and procedure
Sixty eight RA patients (age = 55 ± 13 years, body mass
index: 27.8 ± 5.4 kg/m2, median of disease duration = five
(two to eight) years) participated in this study. The currentmedication of all studied participants appears in Table 1.
The data presented herein are part of a randomised con-
trolled trial study with 100 participants (register number:
ISRCTN04121489); in this study we present the baseline
data from the participants who provided complete data
for objective and subjective PA as well as VO2max data
(68 out of 100). All patients fulfilled the revised American
College of Rheumatology classification criteria for RA [23]
and were recruited from Russells Hall Hospital (Dudley
Group NHS Foundation Trust, UK). The study protocol
and the main trial were approved by Birmingham East,
North and Solihull Research Ethics Committee. All partic-
ipants provided informed consent after verbal and written
information was presented to them about all procedures
involved in the project. Each participant visited the labora-
tory (Clinical Research Unit) on two separate occasions,
seven days apart. During the first visit, participants were
provided with a questionnaire pack, including the Health
Assessment Questionnaire (HAQ) [24] to complete at a
time convenient for themselves. During the same visit, an
accelerometer (GT3X, ActiGraph, Pensacola, FL, USA)
was provided to the participants to be worn over the
subsequent seven consecutive days in order to assess
objective PA. In addition, clinical disease activity and
physical function were assessed as described below.
During the second visit, participants returned the accel-
erometer and questionnaire pack and completed an
assisted long form of the International Physical Activity
Questionnaire (IPAQ) [15], in order to evaluate their sub-
jective PA levels. This was then followed by the assess-
ment of cardiorespiratory fitness, with a VO2max test.
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Height was measured with a Seca Stadiometer 208
while body mass index and body composition were
evaluated via bioelectrical impedance (Tanita BC418-
MA, Tokyo, Japan).
Subjective (self-reported) physical activity
Subjective PA was assessed using the long form of the
IPAQ [15] which has previously been used in the case of
RA patients [19]. The IPAQ measures the level of PA
across four domains, that is, leisure time PA, domestic
and gardening activities, work-related PA, and transport-
related PA. In each domain, the duration (in minutes) and
frequency (days) of PA including sitting, walking, moder-
ate and vigorous PA are self-reported.
Objective physical activity
Daily objective PA and sedentary time (ST) were measured
using the ActiGraph accelerometer (GT3X, Pensacola, FL,
USA). Accelerometry is widely used for assessing individ-
ual levels of daily activity/time spent sedentary across
different age groups ranging from children [25] to older
people [26], as well as in the case of the general population
from different countries [27,28]. The validity and reliability
[29] of the GT3X has been examined against a previous
accelerometer model [30] and across different testing situ-
ations including comparisons between mechanical and
real life settings [19].
Movements recorded by the GT3X are converted into
‘counts’ within each epoch. These counts are calculated
in relation to time spent at different activity intensities
according to different cut-off points [27]. Daily averages
were calculated for different activity levels including ST,
light, moderate, vigorous and moderate-to-vigorous phys-
ical activity (MVPA). The cut-off points applied in the
present study stemmed from Troiano and his colleagues’
research involving more than 6,000 participants [27] (Sed-
entary 0 to 99 counts per minute (CPM), Light 100 to
2,019 CPM, moderate 2,020 to 5,998 CPM and vigorous
5,999 CPM and above, MVPA 2,020 CPM and above). In
the present study, the accelerometers were initialized in
60 second epochs replicating previous research protocols
involving RA patients [17]. Data were screened and to be
included in the analyses, the participant had to have valid
data for a minimum of 10 hours per day [13] and for at
least four days [31].
Participants in the current study were advised to wear
the accelerometer on their waist at all times during a
seven-day period, including their sleeping time if they
did not find this uncomfortable. It was recommended to
the participants that they should only take the device off
during showering, bathing or engaging in any other
water activities. If the participants engaged in any other
water activity which was not possible to record on theaccelerometer, they were requested to report the activity
type, intensity and duration when they returned the de-
vice to the researchers. However, this was not the case
for any of the current study participants.
Assessment of cardiorespiratory fitness (VO2max)
The VO2max test was performed using a breath-by-
breath system (Metalyzer 3B, Leipzig, Germany) on a
HP Cosmos mechanical treadmill (Nussdorf-Traunstein,
Germany). After identifying a convenient speed for each
individual patient (which was normally 2 mph), the speed
increased by 0.5 mph every minute until it reached 4 mph
while inclination remain constant at 1%. Thereafter, there
were only increases in inclination by 1% every 30 seconds
until volitional exhaustion.
Data analysis
Normal distribution of the variables was assessed via the
Kolmogorov-Smirnov normality test. To test our first hy-
pothesis, Bland-Altman plots [32] were used to evaluate
the agreement between the different methods of assessing
PA (that is, subjective versus objective). Furthermore, given
the non-normal distribution of both the subjective (IPAQ)
and objective (GT3X) PA data, the Wilcoxon signed-rank
test was used to test differences between these two
methods for ST, light, moderate and MVPA levels.
To test our second hypothesis, correlations between
VO2max with subjective and objective PA at different
levels were examined via Spearman correlations. Fur-
thermore, Steiger’s Z test [33] was used for analysing the
differences between the correlations of subjective PA
versus VO2max, and objective PA versus VO2max at ST,
light, moderate, vigorous and MVPA levels. All statistical
analyses were conducted using SPSS version 21 for win-
dows package (SPSS, Chicago, IL, USA) with the level of
significance set at P <0.05.
Results
Patient characteristics are reported in Table 1.
Research hypothesis 1: agreement between objective and
subjective physical activity
The Bland-Altman plots
Separate Bland-Altman plots were produced for ST, light
PA, and moderate PA (Figure 1). Results indicated that
the degree of agreement between the different methods
of assessment varies depending on the level of PA tar-
geted. Smaller differences between the subjective and ob-
jective measures emerged when PA was assessed at the
moderate level.
Figures 1A and B demonstrated that the mean differ-
ences between subjective and objective data for seden-
tary behaviour time and light PA were spread evenly in
the graph. Assessment of the Bland-Altman plots for
Figure 1 Bland-Altman plots for minutes per day reported for different level of PA from the GT3X and IPAQ. A) Sedentary level PA.
B) Light level PA. C) Moderate level PA. IPAQ, International Physical Activity Questionnaire; PA, physical activity.
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higher levels of PA, the difference between subjective
and objective PA becomes greater. In these cases, the
subjectively-reported levels were greater than what was
revealed via objective GT3X data. Due to the limited ob-
servations from the GT3X at the vigorous level, it was
not possible to ascertain the pattern of differences be-
tween the two measurements from the Bland-Altman
plots for this level of activity.
Differences between subjective (IPAQ) and objective
(GT3X) physical activity
The results of the Wilcoxon tests between subjective
and objective PA data at different PA levels and the
interquartile ranges are shown in Table 2. Self-reported
sitting (median (interquartile range) = 337 (225 to 451)minutes) was significantly less than objectively mea-
sured ST (median = 596 (510 to 651) minutes; Z = −6.80,
P <0.01). In addition, self-reported light PA (median =
30 (11 to 66) minutes) was also significantly less com-
pared to objective light PA time (median = 267 (221 to
321) minutes; Z = −6.89, P <0.01). In contrast, partici-
pants self-reported significantly more moderate PA be-
haviour on IPAQ (median = 55 (19 to 129) minutes)
than was recorded on GT3X (median = 14 (5 to 25)
minutes; Z = −6.26, P <0.01), and more vigorous PA
(median = 0 (0 to 0) minutes) compared to GT3X (me-
dian = 0 (0 to 0) minutes, Z = −2.83, P = 0.01]. Subjective
participation in MVPA (median = 59 (22 to 148) minutes)
was also significantly elevated compared to MVPA object-
ively measured via GT3X (median = 14 (6 to 26) minutes;
Z = −6.28, P <0.01).
Table 2 Comparisons between IPAQ and accelerometry
data at different physical activity levels and median,
interquartile information
Physical activity level Accelerometry IPAQ (range 0
to 1440)
Z
Sedentary time
(minutes per day)
569 (124 to 765) 337 (82 to 592) −6.80*
Light PA (minutes
per day)
267 (144 to 390) 30 (0 to 87) −6.89*
Moderate PA (minutes
per day)
14 (0 to 34) 55 (0 to 158) −6.26*
MVPA (minutes per day) 14 (0 to 34) 59 (0 to 181) −6.28*
Data reported as median ± interquartile range. *P <0.05. IPAQ, International
Physical Activity Questionnaire; MVPA, moderate to vigorous physical activity;
PA. physical activity.
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(IPAQ) and objective (GT3X) physical activity with VO2max
The average VO2max was 20.17 ± 4.60 ml/minute/kg,
which is indicative of poor fitness levels [11]. Overall,
weak associations emerged between VO2max and subject-
ively reported ST levels, while the correlations between
VO2max and objective PA levels were stronger (Table 3).
VO2max correlated significantly only with subjective
moderate PA (rho = .25, P = 0.01) and MVPA (rho = .27,
P = 0.01) levels. On the other hand, VO2max correlated
significantly with all objective GT3X PA measurements
(light PA rho = .35, P <0.01; moderate PA rho = .34, P =
0.01; MVPA rho = .33, P = 0.01), whereas objective ST was
negatively associated with VO2max fitness (rho = −.27,
P = 0.04).
The tests of the magnitude of the differences between
correlations were examined according to the results of
the Steiger's Z value. Results indicated that only the
differences between the correlations for ST (Z = 3.43,
P <0.001) were significant, whereas at all other levels ofTable 3 The mean, standard deviation, interquartile range fo
variables
Variables M SD IQR (1)
(1) GT3X sedentary (minutes per day) 583 98 142 -
(2) GT3X light PA (minutes per day) 275 79 123 -.78**
(3) GT3X moderate PA (minutes per day) 19 17 20 -.44**
(4) GT3X MVPA (minutes per day) 19 17 20 -.44**
(5) Step counts 5378 2708 3716 -.64**
(6) IPAQ sitting (minutes per day) 290 159 255 .32*
(7) IPAQ walking (minutes per day) 616 653 57 -.18
(8) IPAQ moderate PA (minutes per day) 85 275 103 -.22
(9) IPAQ vigorous PA (minutes per day) 701 785 0 -.09
(10) IPAQ MVPA (minutes per day) 510 731 122 -.24
(11) VO2 max (ml/min/kg) 20.17 4.60 7.17 -.27*
IPAQ, International Physical Activity Questionnaire; IQR, interquartile range; M, mean
standard deviation. *P <0.05, **P <0.01.PA, no significant differences emerged, that is, light PA
(Z = −1.03, P = 0.31), moderate PA (Z = −.04, P = .67),
vigorous PA (Z = −1.10, P = 0.27) and MVPA (Z = −0.43,
P = .67).
Discussion
The present study examined in RA patients: 1) the agree-
ment between subjective/self-reported (IPAQ) and object-
ive (GT3X) PA, and 2) the associations between both of
these assessments with VO2max, the gold standard assess-
ment of cardiorespiratory fitness. Our results show that,
when compared to accelerometry-derived values, RA pa-
tients under-reported ST while in contrast, they over-
reported moderate PA, vigorous PA and MVPA when
these behaviours are assessed using a self-report question-
naire. In addition, we found VO2max to associate more
with objective, in contrast to subjective, PA.
Based on the data obtained from the GT3X, the present
findings indicated that this sample of RA patients had both
lower PA compared to relevant guidelines of 150 minutes
of moderate intensity PA or 75 minutes of vigorous PA per
week (or an equivalent mix of both) [34]. Our results echo
past work [35] that assessed PA (via the QUEST-RA) in
people with RA conducted in different countries, which re-
vealed only a minority of RA patients (13.8%) exercise
more than three times a week. Other research has revealed
that even if RA patients are aware of the guidelines for
PA [36], they generally do not reach recommended
levels of PA. As such, identifying barriers and facilitators
of PA amongst RA patients is certainly an area warrant-
ing future research.
Examination of the agreement between both subjective
and objective PA measurements indicated that the two
measurements varied in their degree of discrepancy at the
different PA levels. The Bland-Altman plots for sedentaryr and Spearman’s correlations between the study
(2) (3) (4) (5) (6) (7) (8) (9) (10)
-
.37** -
.37** 1** -
.59** .78** .78** -
-.37* -.15 -.15 -.33** -
.19 .30* .29* .21 -.24* -
.25* .28* .27* .28* -.25* .42** -
.08 .01 .01 .08 -.00 .16 .34** -
.27* .28* .27* .29* -.24* .43** .98** .45** -
.35** .34** .33* .48** -.02 .11 .25* .19 .27**
; MVPA, moderate to vigorous physical activity; PA, physical activity; SD,
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these two measurements when RA patients were less ac-
tive. Similar patterns have been identified in past work in
the general population [37]; however, the lack of agree-
ment was even larger in the current study as well as when
compared to research on another patient group, that is,
hip osteoarthritis (OA) patients [38]. Even more pro-
nounced than what was the case for hip OA patients, PA
was over reported in our sample of RA patients when
contrasted to what was observed via objective PA meas-
urement. The accelerometry-derived data in the current
study were found to have higher agreement with the gold
standard (VO2max) compared to previous research on
RA patients involving objective assessments of PA [39]. In
the study by Backhouse and colleagues [39], however, ob-
jective PA was assessed during the completion of a walk-
ing task. Participants in the current study were requested
to wear the accelerometer over a seven-day period and,
thus, were likely to be engaging in a variety of activities in-
cluding sedentary behaviours.
In regards to comparing self-reported levels of PA with
the gold standard measure of fitness (VO2max), only
moderate PA and MVPA were significantly correlated
with VO2max. In contrast, all objectively assessed PA
levels as well as time spent sedentary were significantly
associated with cardiorespiratory fitness in the expected
directions. These results suggest that increased engage-
ment in objectively assessed MVPA may lead to increased
cardiorespiratory fitness in the RA population. Increased
cardiorespiratory fitness is important to enhanced car-
diovascular health in RA patients [7,20], as has also
been shown in research on coronary artery disease pa-
tients [40].
Despite the implications of our findings, it is equally im-
portant to acknowledge some of the limitations of the
current study. The sample size was not calculated using
standardized techniques and was limited to a certain geo-
graphical area within the UK. Also, previous research [41]
has indicated that the over-reporting of PA is usually found
in certain groups such as overweight people, which was in-
deed the case for our participants (BMI of >28). However,
it is important to point out that overweight or obese states
are highly prevalent in the RA population [42-44].
Conclusion
Overall, our findings suggest that the observed associa-
tions highlighted a discrepancy between RA patients’
perceptions of their participation in PA and ST (as de-
termined via responses to the IPAQ) and what was the
case objectively. Patients with RA self-reported signifi-
cantly less engagement in sedentary pursuits and signifi-
cantly more moderate and vigorous PA than what were
indicated via accelerometer assessments. Moreover, the
associations between IPAQ-assessed sitting time and PAlevels and the gold standard assessment of PA indicated
that only self-reported moderate and MPVA were corre-
lated with maxVO2 in the expected manner. The present
findings suggest that results from existing studies of RA
patients’ PA and sedentary behaviour patterns that are
based solely on subjective measures of PA and sedentary
behaviour (such as the IPAQ) should be interpreted
with caution.
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